New Capital Management’s Idexx Laboratories IDXX Stock Holding History

New Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$49K	Buy	+100	New	+$50.1K	0.04%	64

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

New Capital Management's IDXX Position: Q1 2021 in Review

New Capital Management opened a new position in Idexx Laboratories (IDXX) in Q1 2021: 100 shares worth $49K. The stake represents 0.04% of the portfolio and ranks #64 among its holdings.

1,011 funds tracked by Wall St. Rank hold IDXX as of Q1 2021.

New Capital Management held 100 shares of Idexx Laboratories worth $49K as of Q1 2021.
Idexx Laboratories was a new New Capital Management position in Q1 2021.
Idexx Laboratories made up 0.04% of New Capital Management's portfolio in Q1 2021, its #64 holding.
1,011 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2021.

Based on New Capital Management's 13F filing for Q1 2021, filed 15 Apr 2021.